Novadiscovery

Novadiscovery is a low-risk technology provider specializing in computer-simulated clinical trials, offering support to biotechnology and pharmaceutical companies, academic research centers, and non-profit organizations. We help clients unlock the potential of modeling and simulation to reduce the R&D risks of new therapies for the benefit of patients. Based on the effect model method, our pioneering approach predicts the efficacy of therapies or the diagnostic value of biomarkers at both individual and population levels and compares them with competitors. Nova can optimize drug development and enhance healthcare decision-making.